Posts in tag

biosimilars


Two new representatives have been welcomed to the GBMA Board, including a former pharmacist The Generic and Biosimilar Medicines Association Independent Chair, Professor Jane Halton and CEO, Marnie Peterson, welcomed …

Biosimilar switching and even administration will be significant parts of full scope of practice – but pharmacists need confidence, says a sector leader Pharmacy stakeholders went to Parliament House, Canberra …

PBAC recommends listing of adalimumab biosimilar The PBAC has recommended the Authority Required listing of adalimumab (Yuflyma) in the form of 40 mg in 0.4 mL pre-filled syringe and pre-filled …

Evidence is pointing to most pharmacists still struggling to come to grips with their role in providing biosimilar medicines It’s now been seven years since the Pharmaceutical Benefits Advisory Committee …

If successful, action could hit pharmacy dispensed biosim Brenzys Multinational pharmaceutical giant Pfizer is suing four other drug companies over allegedly breaching a patent for its rheumatoid arthritis treatment Enbrel …

Rheumatologist, Dr Gerald Tracey explains the opportunities biosimilars present for prescribing physicians, particularly given the government supported streamlined process. Gerald highlights the advantages of collaborative care between the prescriber and …

Trent Twomey, the National President of the Pharmacy Guild of Australia highlights the shifting power dynamic from physicians to patients in determining what medicines they are prescribed. Collaborative care is …

Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …

Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …

George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …

Biosimilars and the pharmacist’s role in their supply remains controversial, writes Carlene McMaugh Biological pharmaceutical products have been a part of the landscape of therapeutics for a number of years …

Here’s what you need to know While there are not many biosimilars available yet in Australia, several have been added to the ARTG and PBS this year. Biosimilar medicines are …